首页> 外文期刊>Biochimica et Biophysica Acta. Protein Structure and Molecular Enzymology >What can the structures of enzyme-inhibitor complexes tell us about the structures of enzyme substrate complexes?
【24h】

What can the structures of enzyme-inhibitor complexes tell us about the structures of enzyme substrate complexes?

机译:关于酶底物复合物的结构,酶抑制剂复合物的结构能告诉我们什么?

获取原文
获取原文并翻译 | 示例
           

摘要

Proteinases perform many beneficial functions that are essential to life, but they are also dangerous and must be controlled. Here we focus on one of the control mechanisms: the ubiquitous presence of protein proteinase inhibitors. We deal only with a subset of these: the standard mechanism, canonical protein inhibitors of serine proteinases. Each of the inhibitory domains of such inhibitors has one reactive site peptide bond, which serves all the cognate enzymes as a substrate. The reactive site peptide bond is in a combining loop which has an identical conformation in all inhibitors and in all enzyme-inhibitor complexes. There are at least 18 families of such inhibitors. They all share the conformation of the combining loops but each has its own global three-dimensional structure. Many three-dimensional structures of enzyme-inhibitor complexes were determined. They are frequently used to predict the conformation of substrates in very short-lived enzyme-substrate transition state complexes. Turkey ovomucoid third domain and eglin c have a Leu residue at P_1. In complexes with chymotrypsin, these P_1 Leu residues assume the same conformation. The relative free energies of binding of P_1 Leu (relative to either P_1 Gly or P_1 Ala) are within experimental error, the same for complexes of turkey ovomucoid third domain, eglin c, P_1 Leu variant of bovine pancreatic trypsin inhibitor and of a substrate with chymotrypsin. Therefore, the P_1 Leu conformation in transition state complexes is predictable. In contrast, the conformation of P_1 Lys~+ is strikingly different in the complexes of Lys~(18) turkey ovomucoid third domain and of bovine pancreatic trypsin inhibitor with chymotrypsin. The relative free energies of binding are also quite different. Yet, the relative free energies of binding are nearly identical for Lys~+ in turkey ovomucoid third domain and in a substrate, thus allowing us to know the structure of the latter. Similar reasoning is applied to a few other systems.
机译:蛋白酶执行许多生命必需的有益功能,但它们也很危险,必须加以控制。在这里,我们着眼于一种控制机制:普遍存在的蛋白酶抑制剂。我们仅处理其中的一个子集:标准机制,丝氨酸蛋白酶的经典蛋白抑制剂。这种抑制剂的每个抑制域都具有一个反应位点肽键,该键将所有同源酶用作底物。活性位点肽键在结合环中,该结合环在所有抑制剂和所有酶抑制剂复合物中均具有相同的构象。至少有18种这类抑制剂。它们都共享组合环的构象,但每个环都有自己的全局三维结构。确定了酶抑制剂复合物的许多三维结构。它们通常用于预测寿命很短的酶-底物过渡态复合物中底物的构象。火鸡卵粘蛋白第三域和eglin c在P_1处具有Leu残基。在与胰凝乳蛋白酶的复合物中,这些P_1 Leu残基具有相同的构象。 P_1 Leu(相对于P_1 Gly或P_1 Ala)结合的相对自由能在实验误差范围内,对于火鸡卵类粘液第三结构域的复合物(例如牛胰胰蛋白酶抑制剂Plin,P_1 Leu变体以及具有胰凝乳蛋白酶。因此,在过渡态复合物中的P_1Leu构象是可预测的。相比之下,P_1 Lys〜+的构象在Lys〜(18)火鸡卵类粘液第三域和牛胰胰蛋白酶抑制剂与胰凝乳蛋白酶的复合物中显着不同。结合的相对自由能也完全不同。然而,在土耳其卵类粘液第三域和底物中,Lys〜+的结合相对自由能几乎相同,因此使我们知道了后者的结构。类似的推理也适用于其他一些系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号